(FIS) Fidelity National - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US31620M1062
Stock: Banking Software, Payment Processing, Financial Services, Risk Management
Total Rating 24
Risk 41
Buy Signal -0.03
| Risk 5d forecast | |
|---|---|
| Volatility | 32.0% |
| Relative Tail Risk | -2.40% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.95 |
| Alpha | -37.11 |
| Character TTM | |
|---|---|
| Beta | 0.684 |
| Beta Downside | 0.179 |
| Drawdowns 3y | |
|---|---|
| Max DD | 47.15% |
| CAGR/Max DD | -0.03 |
EPS (Earnings per Share)
Revenue
Risks
Fundamental:
P/E ratio: 156.25
Description: FIS Fidelity National February 27, 2026
Fidelity National Information Services (FIS) (NYSE: FIS) delivers a broad suite of financial-services technology to banks, capital-market firms, and other institutions, spanning core processing, digital banking, payments, fraud and risk management, as well as treasury and lending solutions. Its operations are organized into Banking Solutions, Capital Market Solutions, and Corporate & Other segments, and the company has been a market leader since its 1968 founding in Jacksonville, Florida.
In its most recent fiscal year (FY 2025), FIS reported revenue of $14.3 billion, up 5.2% year-over-year, driven by strong demand for cloud-based payment processing amid a 9% annual growth in global transaction volumes. The firm’s adjusted EPS reached $6.84, reflecting a 7% margin expansion as operating efficiencies from its recent SaaS migration took hold. Additionally, the U.S. banking sector’s shift toward digital onboarding and real-time payments-accelerated by the Federal Reserve’s Faster Payments Initiative-continues to underpin FIS’s long-term growth outlook.
For a deeper dive into how these trends may affect FIS’s valuation, consider exploring further analysis on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income: 382.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA 3.48 > 1.0 |
| NWC/Revenue: -28.71% < 20% (prev -8.97%; Δ -19.74% < -1%) |
| CFO/TA 0.09 > 3% & CFO 2.96b > Net Income 382.0m |
| Net Debt (3.41b) to EBITDA (3.59b): 0.95 < 3 |
| Current Ratio: 0.59 > 1.5 & < 3 |
| Outstanding Shares: last quarter (519.0m) vs 12m ago -3.89% < -2% |
| Gross Margin: 38.12% > 18% (prev 0.38%; Δ 3774 % > 0.5%) |
| Asset Turnover: 32.39% > 50% (prev 29.98%; Δ 2.42% > 0%) |
| Interest Coverage Ratio: 4.64 > 6 (EBITDA TTM 3.59b / Interest Expense TTM 368.0m) |
Altman Z'' -3.73
| A: -0.09 (Total Current Assets 4.49b - Total Current Liabilities 7.62b) / Total Assets 33.49b |
| B: -0.68 (Retained Earnings -22.72b / Total Assets 33.49b) |
| C: 0.05 (EBIT TTM 1.71b / Avg Total Assets 33.64b) |
| D: -1.19 (Book Value of Equity -23.22b / Total Liabilities 19.59b) |
| Altman-Z'' Score: -3.73 = D |
Beneish M -3.06
| DSRI: 0.98 (Receivables 2.38b/2.25b, Revenue 10.89b/10.13b) |
| GMI: 0.99 (GM 38.12% / 37.58%) |
| AQI: 1.03 (AQ_t 0.85 / AQ_t-1 0.82) |
| SGI: 1.08 (Revenue 10.89b / 10.13b) |
| TATA: -0.08 (NI 382.0m - CFO 2.96b) / TA 33.49b) |
| Beneish M-Score: -3.06 (Cap -4..+1) = AA |
What is the price of FIS shares?
As of March 07, 2026, the stock is trading at USD 51.49 with a total of 7,311,138 shares traded.
Over the past week, the price has changed by +1.04%, over one month by -0.85%, over three months by -21.37% and over the past year by -25.19%.
Over the past week, the price has changed by +1.04%, over one month by -0.85%, over three months by -21.37% and over the past year by -25.19%.
Is FIS a buy, sell or hold?
Fidelity National has received a consensus analysts rating of 3.89.
Therefore, it is recommended to buy FIS.
- StrongBuy: 10
- Buy: 6
- Hold: 11
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the FIS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 67.1 | 30.3% |
| Analysts Target Price | 67.1 | 30.3% |
FIS Fundamental Data Overview March 04, 2026
P/E Trailing = 156.25
P/E Forward = 8.1169
P/S = 2.4463
P/B = 1.9042
P/EG = 0.4098
Revenue TTM = 10.89b USD
EBIT TTM = 1.71b USD
EBITDA TTM = 3.59b USD
Long Term Debt = 8.90b USD (from longTermDebt, two quarters ago)
Short Term Debt = 4.01b USD (from shortTermDebt, last quarter)
Debt = 4.01b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.41b USD (from netDebt column, last quarter)
Enterprise Value = 29.53b USD (26.12b + Debt 4.01b - CCE 599.0m)
Interest Coverage Ratio = 4.64 (Ebit TTM 1.71b / Interest Expense TTM 368.0m)
EV/FCF = 10.51x (Enterprise Value 29.53b / FCF TTM 2.81b)
FCF Yield = 9.51% (FCF TTM 2.81b / Enterprise Value 29.53b)
FCF Margin = 25.78% (FCF TTM 2.81b / Revenue TTM 10.89b)
Net Margin = 3.51% (Net Income TTM 382.0m / Revenue TTM 10.89b)
Gross Margin = 38.12% ((Revenue TTM 10.89b - Cost of Revenue TTM 6.74b) / Revenue TTM)
Gross Margin QoQ = 38.26% (prev 42.45%)
Tobins Q-Ratio = 0.88 (Enterprise Value 29.53b / Total Assets 33.49b)
Interest Expense / Debt = 2.19% (Interest Expense 88.0m / Debt 4.01b)
Taxrate = 14.24% (85.0m / 597.0m)
NOPAT = 1.47b (EBIT 1.71b * (1 - 14.24%))
Current Ratio = 0.59 (Total Current Assets 4.49b / Total Current Liabilities 7.62b)
Debt / Equity = 0.29 (Debt 4.01b / totalStockholderEquity, last quarter 13.90b)
Debt / EBITDA = 0.95 (Net Debt 3.41b / EBITDA 3.59b)
Debt / FCF = 1.22 (Net Debt 3.41b / FCF TTM 2.81b)
Total Stockholder Equity = 14.25b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.14% (Net Income 382.0m / Total Assets 33.49b)
RoE = 2.68% (Net Income TTM 382.0m / Total Stockholder Equity 14.25b)
RoCE = 7.38% (EBIT 1.71b / Capital Employed (Equity 14.25b + L.T.Debt 8.90b))
RoIC = 5.43% (NOPAT 1.47b / Invested Capital 27.01b)
WACC = 7.57% (E(26.12b)/V(30.13b) * Re(8.44%) + D(4.01b)/V(30.13b) * Rd(2.19%) * (1-Tc(0.14)))
Discount Rate = 8.44% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -6.29%
[DCF] Terminal Value 79.02% ; FCFF base≈2.35b ; Y1≈2.24b ; Y5≈2.15b
[DCF] Fair Price = 73.81 (EV 41.64b - Net Debt 3.41b = Equity 38.22b / Shares 517.9m; r=7.57% [WACC]; 5y FCF grow -6.21% → 2.90% )
EPS Correlation: -24.17 | EPS CAGR: 3.62% | SUE: 0.0 | # QB: 0
Revenue Correlation: -24.20 | Revenue CAGR: -5.61% | SUE: 0.78 | # QB: 0
EPS next Quarter (2026-06-30): EPS=1.50 | Chg7d=+0.001 | Chg30d=-0.013 | Revisions Net=+1 | Analysts=17
EPS current Year (2026-12-31): EPS=6.28 | Chg7d=+0.021 | Chg30d=+0.027 | Revisions Net=+2 | Growth EPS=+9.1% | Growth Revenue=+29.0%
EPS next Year (2027-12-31): EPS=6.86 | Chg7d=-0.028 | Chg30d=-0.007 | Revisions Net=-1 | Growth EPS=+9.3% | Growth Revenue=+4.8%
[Analyst] Revisions Ratio: +1.00 (1 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 7.8% (Discount Rate 8.4% - Earnings Yield 0.6%)
[Growth] Growth Spread = +22.0% (Analyst 29.8% - Implied 7.8%)
P/E Forward = 8.1169
P/S = 2.4463
P/B = 1.9042
P/EG = 0.4098
Revenue TTM = 10.89b USD
EBIT TTM = 1.71b USD
EBITDA TTM = 3.59b USD
Long Term Debt = 8.90b USD (from longTermDebt, two quarters ago)
Short Term Debt = 4.01b USD (from shortTermDebt, last quarter)
Debt = 4.01b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.41b USD (from netDebt column, last quarter)
Enterprise Value = 29.53b USD (26.12b + Debt 4.01b - CCE 599.0m)
Interest Coverage Ratio = 4.64 (Ebit TTM 1.71b / Interest Expense TTM 368.0m)
EV/FCF = 10.51x (Enterprise Value 29.53b / FCF TTM 2.81b)
FCF Yield = 9.51% (FCF TTM 2.81b / Enterprise Value 29.53b)
FCF Margin = 25.78% (FCF TTM 2.81b / Revenue TTM 10.89b)
Net Margin = 3.51% (Net Income TTM 382.0m / Revenue TTM 10.89b)
Gross Margin = 38.12% ((Revenue TTM 10.89b - Cost of Revenue TTM 6.74b) / Revenue TTM)
Gross Margin QoQ = 38.26% (prev 42.45%)
Tobins Q-Ratio = 0.88 (Enterprise Value 29.53b / Total Assets 33.49b)
Interest Expense / Debt = 2.19% (Interest Expense 88.0m / Debt 4.01b)
Taxrate = 14.24% (85.0m / 597.0m)
NOPAT = 1.47b (EBIT 1.71b * (1 - 14.24%))
Current Ratio = 0.59 (Total Current Assets 4.49b / Total Current Liabilities 7.62b)
Debt / Equity = 0.29 (Debt 4.01b / totalStockholderEquity, last quarter 13.90b)
Debt / EBITDA = 0.95 (Net Debt 3.41b / EBITDA 3.59b)
Debt / FCF = 1.22 (Net Debt 3.41b / FCF TTM 2.81b)
Total Stockholder Equity = 14.25b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.14% (Net Income 382.0m / Total Assets 33.49b)
RoE = 2.68% (Net Income TTM 382.0m / Total Stockholder Equity 14.25b)
RoCE = 7.38% (EBIT 1.71b / Capital Employed (Equity 14.25b + L.T.Debt 8.90b))
RoIC = 5.43% (NOPAT 1.47b / Invested Capital 27.01b)
WACC = 7.57% (E(26.12b)/V(30.13b) * Re(8.44%) + D(4.01b)/V(30.13b) * Rd(2.19%) * (1-Tc(0.14)))
Discount Rate = 8.44% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -6.29%
[DCF] Terminal Value 79.02% ; FCFF base≈2.35b ; Y1≈2.24b ; Y5≈2.15b
[DCF] Fair Price = 73.81 (EV 41.64b - Net Debt 3.41b = Equity 38.22b / Shares 517.9m; r=7.57% [WACC]; 5y FCF grow -6.21% → 2.90% )
EPS Correlation: -24.17 | EPS CAGR: 3.62% | SUE: 0.0 | # QB: 0
Revenue Correlation: -24.20 | Revenue CAGR: -5.61% | SUE: 0.78 | # QB: 0
EPS next Quarter (2026-06-30): EPS=1.50 | Chg7d=+0.001 | Chg30d=-0.013 | Revisions Net=+1 | Analysts=17
EPS current Year (2026-12-31): EPS=6.28 | Chg7d=+0.021 | Chg30d=+0.027 | Revisions Net=+2 | Growth EPS=+9.1% | Growth Revenue=+29.0%
EPS next Year (2027-12-31): EPS=6.86 | Chg7d=-0.028 | Chg30d=-0.007 | Revisions Net=-1 | Growth EPS=+9.3% | Growth Revenue=+4.8%
[Analyst] Revisions Ratio: +1.00 (1 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 7.8% (Discount Rate 8.4% - Earnings Yield 0.6%)
[Growth] Growth Spread = +22.0% (Analyst 29.8% - Implied 7.8%)